REQUEST A DEMO
Total
USD $0.00
Search more companies

Akura Medicamentos Especiais S.A. (Serra) (Brazil)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Other Health and Personal Care Stores
Full name: Akura Medicamentos Especiais S.A. Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Portuguese Download a sample report

Akura Medicamentos Especiais S.A. (Serra) is an enterprise located in Brazil, with the main office in Serra. It operates in the Pharmacies and Drug Stores industry. The company was established on September 22, 2021. The latest financial highlights indicate a net sales revenue increase of 85.31% in 2023. Its total assets grew by 55.61% over the same period. The net profit margin of Akura Medicamentos Especiais S.A. (Serra) decreased by 8.81% in 2023.

Headquarters
Rua Samuel Meira Brasil 394, Sala 52, Taquara II
Serra; Espirito Santo; Postal Code: 29167650

Contact Details: Purchase the Akura Medicamentos Especiais S.A. (Serra) report to view the information.

Basic Information
Outstanding Shares:
Purchase the Akura Medicamentos Especiais S.A. (Serra) report to view the information.
Registered Capital:
Purchase the Akura Medicamentos Especiais S.A. (Serra) report to view the information.
Incorporation Date:
September 22, 2021
Key Executives
Purchase this report to view the information.
President
Company Performance
Financial values in the chart are available after Akura Medicamentos Especiais S.A. (Serra) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
85.31%
Total operating revenue
85.31%
Operating profit (EBIT)
30.51%
Net Profit (Loss) for the Period
28.12%
Total assets
55.61%
Total equity
86.47%
Operating Profit Margin (ROS)
-7.68%
Net Profit Margin
-8.81%
Return on Equity (ROE)
-21.12%
Debt to Equity Ratio
-34.62%
Quick Ratio
0.32%
Cash Ratio
0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?